CCA
VASC

Conestoga Capital Advisors’s Vascular Solutions Inc VASC Stock Holding History

Conestoga Capital Advisors’s Portfolio VASC Stock Details VASC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-778,246
Closed -$43.7M – 121
2016
Q4 		$43.7M Sell
778,246
-133,930
-15% -$6.82M 2.91% 10
2016
Q3 		$44M Sell
912,176
-147,935
-14% -$6.89M 3.02% 6
2016
Q2 		$44.2M Sell
1,060,111
-185,972
-15% -$6.92M 3.26% 3
2016
Q1 		$40.5M Buy
1,246,083
+389,972
+46% +$11.2M 2.74% 13
2015
Q4 		$29.4M Buy
856,111
+137,615
+19% +$4.66M 2.38% 18
2015
Q3 		$23.3M Sell
718,496
-13,799
-2% -$494K 1.87% 29
2015
Q2 		$25.4M Sell
732,295
-12,210
-2% -$398K 1.76% 33
2015
Q1 		$22.6M Buy
744,505
+279,275
+60% +$8.02M 1.55% 34
2014
Q4 		$12.6M Buy
465,230
+340,428
+273% +$9.24M 0.88% 45
2014
Q3 		$3.08M Buy
+124,802
New +$2.96M 0.23% 49

Other funds holding VASC

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Conestoga Capital Advisors's VASC Position: Q1 2017 in Review

Conestoga Capital Advisors sold out of Vascular Solutions Inc (VASC) in Q1 2017, closing a stake of 778,246 shares — an estimated $43.7M sold.

Conestoga Capital Advisors first reported a position in VASC in Q3 2014 and held it in 10 quarters. The position peaked at $44.2M in Q2 2016. 1 fund tracked by Wall St. Rank holds VASC as of Q1 2017.

  • Conestoga Capital Advisors reported no remaining Vascular Solutions Inc position as of Q1 2017 after selling out during the quarter.
  • Conestoga Capital Advisors sold 778,246 Vascular Solutions Inc shares in Q1 2017, an estimated $43.7M.
  • Conestoga Capital Advisors first reported a position in Vascular Solutions Inc in Q3 2014 and held it in 10 quarters.
  • Conestoga Capital Advisors's Vascular Solutions Inc position peaked at $44.2M in Q2 2016.
  • 1 fund tracked by Wall St. Rank held Vascular Solutions Inc as of Q1 2017.

Based on Conestoga Capital Advisors's 13F filing for Q1 2017, filed 19 Apr 2017.